A systematic review and meta-analysis support greater reduction of proteinuria in patients with IgA nephropathy.

Proteinuria is a condition characterised by the presence of excess protein, mainly albumin, in the urine. Generally, the kidneys filter waste products and excess fluids from the blood and excrete them ...

Medically reviewed by Matthew Wosnitzer, MD Key Takeaways Proteinuria affects most people with complement 3 glomerulopathy ...

Analysis published in ASN, highlighted compelling evidence that ERAs offer substantial therapeutic benefits for CKD patients.

Proteinuria is common in the adult population and its clinical significance can vary widely. A clear diagnostic process is needed to identify the cause of the findings and guide the treatment ...

Low proteinuria does not indicate better kidney outcomes or treatment response in patients with lupus nephritis; glomerulosclerosis predicts renal function decline, especially in relapsing disease.

February 16, 2010 — Proteinuria may help predict outcomes in chronic kidney disease (CKD) independent of estimated glomerular filtration rate (eGFR) level, according to the results of a ...

Before a drug is marketed in the US, it must be shown to be safe and effective for its intended use. The clearest evidence of a drug's effectiveness comes from studies establishing its effects on ...

Please provide your email address to receive an email when new articles are posted on . At 36 weeks, patients receiving sparsentan experienced a mean 49.8% reduction in proteinuria from baseline.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Measuring proteinuria within 48 hours of hospital ...

Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Proteinuria Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Proteinuria ...